Wells Fargo & Company Vanda Pharmaceuticals Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 20,467 shares of VNDA stock, worth $125,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,467

Previous 17,700 15.63%

Holding current value

$125,053

Previous $74,000 13.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.47 - $4.61 $9,601 - $12,755	2,767 Added 15.63%	20,467 $84,000
Q4 2023 Feb 09, 2024	BUY	$3.38 - $4.58 $10,714 - $14,518	3,170 Added 21.82%	17,700 $74,000
Q3 2023 Nov 13, 2023	SELL	$4.28 - $6.57 $204,365 - $313,710	-47,749 Reduced 76.67%	14,530 $62,000
Q2 2023 Aug 15, 2023	BUY	$5.9 - $6.95 $61,731 - $72,717	10,463 Added 20.19%	62,279 $410,000
Q1 2023 May 12, 2023	BUY	$6.18 - $7.99 $307,955 - $398,149	49,831 Added 2510.38%	51,816 $351,000

Q4 2022 Feb 13, 2023	SELL	$6.87 - $10.96 $17,580 - $28,046	-2,559 Reduced 56.32%	1,985 $14,000
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $4,332 - $5,397	-459 Reduced 9.17%	4,544 $46,000
Q2 2022 Aug 12, 2022	SELL	$9.31 - $11.84 $753,225 - $957,915	-80,905 Reduced 94.18%	5,003 $54,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $162,545 - $248,167	-14,995 Reduced 14.86%	85,908 $971,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $3.3 Million - $4.44 Million	-210,030 Reduced 67.55%	100,903 $1.58 Million
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $1.62 Million - $2.24 Million	-105,267 Reduced 25.29%	310,933 $5.33 Million
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $4.24 Million - $5.8 Million	269,632 Added 183.96%	416,200 $8.95 Million
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $78,533 - $118,678	5,852 Added 4.16%	146,568 $2.2 Million
Q4 2020 Feb 09, 2021	BUY	$9.77 - $13.81 $73,548 - $103,961	7,528 Added 5.65%	140,716 $1.85 Million
Q3 2020 Nov 05, 2020	SELL	$9.32 - $12.02 $84,457 - $108,925	-9,062 Reduced 6.37%	133,188 $1.29 Million
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $523,948 - $651,952	-54,239 Reduced 27.6%	142,250 $1.63 Million
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $1.47 Million - $3.3 Million	196,489 New	196,489 $2.04 Million

Others Institutions Holding VNDA

# of Institutions

151

Shares Held

49.2M

Call Options Held

49.1K

Put Options Held

107K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $346M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Vanda Pharmaceuticals Inc. Transaction History